1. P.07.1 SWITCHING FROM INFLIXIMAB ORIGINATOR TO A FIRST BIO SIMILAR IS SAFE AND EFFECTIVE. A SINGLE CENTER SERIES WITH THROUGH LEVELS AND ANTI-DRUG ANTIBODIES DETERMINATION. Issue 2 (15th March 2018) Authors: Daperno, M.; Guiotto, C.; Italia, A.; Lavagna, A.; Negri, A.; Ercole, E.; Cosimato, M.; Rigazio, C.; Rocca, R. Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018)Supplement Page Start: e192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗